Western blot analysis of NFκB p50 phosphorylation in untreated (A,D), calyculin A treated (B,E) and calyculin A and lambda protein phosphatase treated (C,F) HeLa whole cell lysates. Antibodies tested include p-NFκB p50 (Ser 932): sc-101747 (A,B,C) and NFκB p50 (E-10): sc-8414 (D,E,F).
p-NFκB p105/p50 (Ser 932): sc-101747. Western blot analysis of phosphorylated NFκB p105 expression in untreated (A) and TNFα + Calyculin A-treated (B) HeLa whole cell lysates.
p-NFκB p105/p50 (Ser 932): sc-101747. Immunoperoxidase staining of formalin-fixed, paraffin-embedded human breast carcinoma tissue showing cytoplasmic staining.
Western blot analysis of NFκB p105 phosphorylation in untreated (A, D), calyculin A treated (B, E) and calyculin A and lambda protein phosphatase treated (C, F) HeLa whole cell lysates. Antibodies tested include p-NKκB p105 (Ser 932): sc-101747 (A, B, C) and NFκB p50 (H-119): sc-7178 (D, E, F).
Western blot analysis of NFκB p50 phosphorylation in untreated (A,D), TNF and calyculin A treated (B,E) and TNF, calyculin A and lambda protein phosphatase treated (C,F) HeLa whole cell lysates. Antibodies tested include p-NFκB p50 (Ser 932): sc-101747 (A,B,C) and NFκB p50 (E-10): sc-8414 (D,E,F).